Two treatments of combined AFL and IM show potential to treat low-risk BCCs with acceptable tolerability. OCT and RCM show promise to detect subclinical BCCs at short-term follow up.
Deficits in use of sunscreen indicate that people pay little attention to the recommendations of health authorities, regardless of their skin type, and underscore an urgent need for targeted public information on its use.
From 2012 to 2014, 41,185 patients with a diagnosis of skin malignancy of the head and neck region were identified, mostly with a diagnosis of nonmelanoma skin cancer.
For nonelderly adults in the United States, having Medicaid or no health insurance is associated with increased odds of being diagnosed with late-stage melanoma compared with having private insurance.
Reflectance confocal microscopy may be more accurate than dermoscopy for the diagnosis of amelanotic/hypomelanotic melanoma, study results suggest.
Researchers evaluated the risk for nonmelanoma skin cancer in patients receiving anti-tumor necrosis factor (TNF) inhibitors vs those who did not receive anti-TNFs.
Awareness of poorer survival in men with melanoma — and prevention — might lead to lower incidence and mortality.
Diagnosis and management of EF in the setting of cancer immunotherapy requires close collaboration between patient’s oncologist, dermatologist, and rheumatologist.
Clinical factors such as history of solid organ transplantation, presence of diabetes, history of other malignancies, and poor histologic differentiation were significant risk factors for recurrence of cutaneous SCC in Asian patients treated with Mohs surgery.
A strong influence of progestogens used before menopause on melanoma risk was not supported by novel study results, nor do they support a phototoxic effect of progestogens in melanoma risk.
